Mayo Clinic Platform Standardizes Cancer Data to Speed Trials
What you should know
- The update: Mayo Clinic Platform_Orchestra has launched new capabilities that allow researchers to access standardized, “research-ready” cancer data.
- The standard: The platform now uses the OMOP Oncology framework, which structures complex and confusing data (such as pathology reports and tumor staging) into a consistent format that algorithms can easily analyze.
- The future: Later this year, Mayo will introduce tokenization, a technology that connects de-identified patient data across different health systems, giving researchers a complete “longitudinal view” of a cancer patient’s journey before, during and after their stay at Mayo.
Structure the unstructured
The main innovation here is the integration of Oncology OMOP (Observational Medical Outcomes Partnership). This global standard allows the platform to ingest unstructured data (such as a doctor’s handwritten notes or a radiology report) and refine it into structured attributes.
- Tickets: Diagnoses, laboratory results, images, pathology reports.
- Departures: Standardized tumor characteristics, biomarkers, staging and progression data.
“Integrating OMOP Oncology into the Mayo Clinic platform has the power to accelerate discovery, improve clinical trial design, unlock real-world insights and support the development of next-generation therapies for patients around the world,” he said. Elisabeth Heath, MDchairman of the Department of Oncology at Mayo Clinic.
The “longitudinal” view
Later this year, the platform will incorporate tokenization. Currently, a hospital often only cares for a patient when they are within its walls. Tokenization makes it possible to connect de-identified data across the healthcare ecosystem. This gives researchers a “longitudinal view” – following a patient’s journey before They arrived in May and after they left. This is critical to understanding long-term survival and real-world effectiveness of treatments outside of a controlled trial setting.
Cheers Nemesisa provider of research and technology services for the Mayo Clinic Platform, contributed to the development of OMOP Oncology capabilities in Orchestrate.
